Photocure ASA (LON:0IMT)

Market Cap	111.38M
Revenue (ttm)	39.19M
Net Income (ttm)	157.30K
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	708.04
Forward PE	161.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47
Average Volume	1,586
Open	57.20
Previous Close	n/a
Day's Range	57.20 - 57.20
52-Week Range	48.00 - 64.40
Beta	0.78
RSI	67.99
Earnings Date	Jul 30, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Employees: 101
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IMT

Financial Performance

Financial numbers in NOK